50% off all subscriptions! ... left. Order NowOrder Now

Madrigal Pharmaceuticals, Inc. Stock Forecast NASDAQ:MDGL

$82.06 (-3.62%)

Volume: 93k

Closed: Nov 26, 2021

Hollow Logo Score: -1.296

Madrigal Pharmaceuticals, Inc. Stock Forecast

$82.06 (-3.62%)

Volume: 93k

Closed: Nov 26, 2021

Score Hollow Logo -1.296
Which way will MDGL go? Request
Key Stats
Beta 0.7
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 27 and the stock is currently not being overbought or oversold

Weaker technical forecast for Madrigal Pharmaceuticals, Inc. as stock downgraded to Sell Candidate.
(Updated on Nov 26, 2021)

Sell candidate since 2021-11-24 Loss -3.62%

The Madrigal Pharmaceuticals, Inc. stock price fell by -3.62% on the last day (Friday, 26th Nov 2021) from $85.14 to $82.06. During the day the stock fluctuated 4.49% from a day low at $81.00 to a day high of $84.64. The price has fallen in 8 of the last 10 days and is down by -10.71% for this period. Volume has increased on the last day by 23 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 93 thousand shares were bought and sold for approximately $7.63 million.

The stock lies in the lower part of a wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $80.96 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 7.51% during the next 3 months and, with a 90% probability hold a price between $87.04 and $103.96 at the end of this 3-month period.

Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, November 22, 2021, and so far it has risen 1.76%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Madrigal Pharmaceuticals, Inc. stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $83.23 and $84.25. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss

Madrigal Pharmaceuticals, Inc. finds support from accumulated volume at $81.74 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $3.64 between high and low, or 4.49%. For the last week, the stock has had a daily average volatility of 4.70%.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Madrigal Pharmaceuticals, Inc. stock A Buy?

The Madrigal Pharmaceuticals, Inc. stock holds several negative signals and despite the positive trend, we believe Madrigal Pharmaceuticals, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

Current score: -1.296

Predicted Opening Price for Madrigal Pharmaceuticals, Inc. of Monday, November 29, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price November 29, 2021 Current price
$82.57 $82.06 (Undervalued)
Sell Candidate Downgraded

Remember To Visit Our YouTube Channel

Analyst Ratings

On Nov 17, 2021 "JMP Securities" gave "$219.00" rating for MDGL. The price target was changed from $86.99 to 2.8%.

Volatility and Risk
Daily Average Volatility: 4.70 %
Overall Risk: Very High High Medium Low Very Low
4.70 %
Daily Average Volatility
Overall Risk

Very High
Very Low

Support & Resistance

Resistance: $93.04
Price: $82.06
Support: $81.74

MDGL Insider Trading Show all Trades



Last 100 transactions
Buy: 1 069 685 | Sell: 7 139 603 (Shares)
Date Action Amount Person Type
Nov 01, 2021 Buy 5 000 Howarth Alex G. Stock Option (Right to Buy)
Aug 02, 2021 Buy 35 000 Waltermire Robert E. Call Option
Jun 17, 2021 Buy 12 489 Levy Richard S Stock Option (Right to buy)
Jun 17, 2021 Buy 12 489 Gollust Keith R Stock Option (Right to Buy)
Jun 17, 2021 Buy 12 489 Craves Fred B Stock Option (Right to Buy)
Show all Insider Trades


Last 100 transactions
Buy: 1 069 685 | Sell: 7 139 603 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 86.21 5.05 %
84.82 3.36 %
83.96 2.31 %
Current price: 82.06
Support 81.18 -1.08 %
80.32 -2.12 %
78.93 -3.82 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 95.09 15.88 %
93.54 13.99 %
93.04 13.38 %
Current price 82.06
Support 81.74 -0.39%
78.62 -4.19%
78.35 -4.52%

Click to get the best stock tips daily for free!

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE